These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 946896)

  • 1. Serotherapy of malignant disease.
    Wright PW; Hellström KE; Hellström IE; Bernstein ID
    Med Clin North Am; 1976 May; 60(3):607-22. PubMed ID: 946896
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of BCG in the treatment of human neoplasms: a review.
    Nathanson L
    Semin Oncol; 1974 Dec; 1(4):337-50. PubMed ID: 4620439
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukemia and lymphoma.
    White LP
    Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of BCG vaccination in producing tumor immunity. An experimental study.
    Ariyan S; Gershon RK
    Plast Reconstr Surg; 1975 Oct; 56(4):430-7. PubMed ID: 1174267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotherapy of malignant disease.
    Wright PW; Bernstein ID
    Prog Exp Tumor Res; 1980; 25():140-62. PubMed ID: 6986629
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunity reactions and the pharmacotherapy of malignant neoplasms (allergy and cancer)].
    Ado VA
    Fiziol Zh; 1976; 22(2):265-71. PubMed ID: 791690
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of malignant human neoplasms with L-asparaginase].
    Oettgen HF; Schulten HK
    Klin Wochenschr; 1969 Jan; 47(2):65-71. PubMed ID: 4904782
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in tumor immunology (a review). Is cancer a disease of immune mechanisms?
    Stoloff IL
    Del Med J; 1971 May; 43(5):121-3. PubMed ID: 5283370
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relationship between immunity and disease course in hemoblastoses].
    Tilz GP
    Wien Med Wochenschr; 1972 Nov; 122(43):646-9. PubMed ID: 4655806
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical antitumor activity and toxicity of streptozotocin (NSC-85998).
    Schein PS; O'Connell MJ; Blom J; Hubbard S; Magrath IT; Bergevin P; Wiernik PH; Ziegler JL; DeVita VT
    Cancer; 1974 Oct; 34(4):993-1000. PubMed ID: 4371075
    [No Abstract]   [Full Text] [Related]  

  • 11. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
    Galli SJ; Adams RA
    Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM; Close HP
    Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithymocyte antisera theapy in nonsurgical immunologic disease.
    Pirofsky B; Reid RH; Bardana EJ; Bayrakci C
    Transplant Proc; 1971 Mar; 3(1):769-72. PubMed ID: 4999470
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of immunology in the diagnosis and treatment of cancer.
    Humphrey LJ; Pierce GE
    Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunology of tumors.
    Burk MW; Mckhann CF
    Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XL. Plant extracts.
    Abbott BJ; Hartwell JL; Leiter J; Perdue RE; Schepartz SA
    Cancer Res; 1967 Mar; 27(3 Pt 2):190-345. PubMed ID: 4289800
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment.
    Gunvén P; Klein G; Henle W; Henle G; Rocchi G; Hewetson JF; Guerra A; Clifford P; Singh S; Demissie A; Svedmyr A
    Int J Cancer; 1973 Jul; 12(1):115-23. PubMed ID: 4364265
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific afferent interference by antiserum of in vivo immunity.
    Ting C; Herberman RB
    Nature; 1975 Oct; 257(5529):801-2. PubMed ID: 52846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.